IGF1 and neoplasm: Besides gliomagenesis, MADM has also been used to study the evolution of medulloblastoma and showed tumor cells transdifferentiate to astrocytes, which promote the cancer progression via increasing the release of IGF1 from the tumor-associated microglia (82).